From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM
Objectives: In 2017, the World Health Organization (WHO) medical eligibility criteria (MEC) for contraception category for intramuscular depot medroxyprogesterone acetate (DMPA-IM) was changed from MEC category 1 to 2 for women at high risk of HIV acquisition. We assessed the impact of communicating...
Saved in:
Main Authors: | Petrus Steyn (Author), Mags Beksinska (Author), Melanie Pleaner (Author), Hui-Zhen Tam (Author), Jenni Smit (Author), Kathy Baisley (Author), Douglas Taylor (Author), Mandisa Singata-Madliki (Author), G. Justus Hofmeyr (Author), Thesla Palanee-Phillips (Author), James N. Kiarie (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
by: G. Justus Hofmeyr, et al.
Published: (2024) -
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial
by: Mandisa Singata-Madliki, et al.
Published: (2021) -
Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial
by: Rebecca Ryan, et al.
Published: (2022) -
Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience
by: Irina Yacobson, et al.
Published: (2023) -
Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status
by: Mags E. Beksinska, et al.
Published: (2018)